ICHR
Overvalued by 86.6% based on the discounted cash flow analysis.
Market cap | $1.26 Billion |
---|---|
Enterprise Value | $1.43 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-1.47 |
Beta | 0.0 |
Outstanding Shares | 32,966,846 |
Avg 30 Day Volume | 259,208 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -29.26 |
---|---|
PEG | 15.92 |
Price to Sales | 1.57 |
Price to Book Ratio | 2.21 |
Enterprise Value to Revenue | 1.76 |
Enterprise Value to EBIT | -130.92 |
Enterprise Value to Net Income | -34 |
Total Debt to Enterprise | 0.17 |
Debt to Equity | 0.44 |
No data
No data